Editorial comment: The authors importantly describe possible factors that may be involved in the pathophysiology of erectile dysfunction observed in both types I and II diabetes. Two chronically diabetic rat models, determined to have near absent penile re¯exes unlike that of controls, were similarly found to have altered generation of nitric oxide (NO) in the penis accompanied by decreased serum testosterone levels. These alterations pertained to reductions in nitric oxide synthesis and in content of the constitutive neuronal isoform of nitric oxide synthase (NOS), both of which as the authors indicate are linked to androgen de®ciency. Since endogenous NOS inhibition was not shown in NOS activity assays using diabetic penile cytosol, the authors also conclude that advanced glycation endproducts that accumulate in diabetic tissues do not affect NO-mediated erectile responses. The association between hypogonadism and altered NO release observed in this study reinforces a concept that may be applied to other chronic diseases or conditions with risk factors for erectile dysfunction and is in agreement with other non-diabetic disease models studied by these and other investigators. While this work provides direct evidence that neuronal NOS regulation of penile erectile responses is altered in chronic diabetes, forthcoming studies may be necessary to conclude whether and to what extent this disease pertains to altered expression and function of endothelial NOS in the penis.
penis although this investigation centers on the function of the rat corpus spongiosum. They describe rather signi®cant suprasystolic pressure increases in the corpus spongiosum, concurrent with bulbospongiosus muscle bursts, during re¯ex-ive penile erections. These data characterize mechanisms involved in glans engorgement as well as penile shaft rigidity that may have general signi®-cance.
AL Burnett, MD
Neural and endothelial nitric oxide synthase activity in rat penile erectile tissue WG Dail, V Barba, L Leyba, R Galindo Department of Anatomy, University of New Mexico School of Medicine, Albuquerque, New Mexico Cell Tissue Res 1995; 282: 109±116.
Editorial comment: This comprehensive study features the ®rst apparent immunohistochemical description of endothelial nitric oxide synthase (NOS) in penile tissue. The ®ndings af®rm the notion that penile endothelial cells are capable of biosynthesizing and releasing nitric oxide (NO). Observations generally parallel previously published histochemical results using the NADPH-diaphorase technique and immunohistochemical ®ndings using a neuronal NOS antibody which cross-reacts with NOS in endothelial cells. Interestingly, the authors observe a lack of staining involving the endothelium of cavernous sinuses, from which they infer a limited role for endothelial NOS in in¯uencing rat carvernosal tissue relaxation. Further determinations of penile endothelial NOS immunoreactivity in other species are needed to make comparisons. The actual functional contribution of penile endothelial NOS to NO-mediated penile erection in various species also awaits additional investigations.
Reproducibility of penile arterial colour duplex ultrasonography RD Mills and KK Sethia The Department of Urology, The Norfolk and Norwich Hospital, Norwich, UK Br J Urol 1996; 78: 109±112.
Colour duplex ultrasonography of the penile arteries (CDU) was performed in 58 patients, on two occasions 2 weeks apart. Papaverine 60 mg was used intracavernosally before CDU in 34 cases and a mixture of papaverine, phentolamine and prostaglandin E1 in 24 cases. In both group of patients the reproducibility was poor for all variables measured.
Editorial comment: There are several factors which need to be considered when selecting diagnostic methods: reliability, reproducibility, cost and the value of information obtained. This study clearly shows, once again, the two major problems of the hemodynamic testing: (a) the degree of smooth muscle relaxation and (b) the lack of standardization of the screening procedures. Regarding the ®rst problem, as the authors stated,`the only practical way to achieve constancy of relaxation is to obtain complete smooth muscle'. It is well established that there is no relationship between the dose or type of intracavernosal vasoactive agents and any corporal veno-occlusive or arterial hemodynamic parameter. Redosing of vasodilators is the only available method to overcome incomplete trabecular smooth muscle relaxation in the majority of the cases. The second problem is also well documented and standardization is urgently needed, not only for better patient care, but also for objective comparison and evaluation of the clinical studies.
D Hatzichristou, MD, PhD
Penile prostheses in paraplegic men AJ Gross, DH Sauerwein, J Kutzenberger, R-H Ringert Klinik fur Urologie, Georg-August-Universitat, Gottingen and Department III, Neuro-Urologie, Werner Wicker Klinik, Bad Wildungen, Germany Br J Urol 1996; 78: 262±264.
The authors reported on the ef®cacy of penile prosthesis implantation in 179 paralysed patients. Indication for implantation was erectile dysfunction, penile retraction, or a combination of both. Semi-rigid (Jonas), hydraulic (AMS Hydro¯ex) and exible (AMS 700) devices were used. With a mean follow-up of ®ve years, 84% of the 83 patients with leading indication erectile dysfunction reported that the prostheses enabled them to perform satisfactory sexual intercourse, while 92% of the 126, who wanted to use their implant for external condom drainage, were able to do so. Perforation rate was 7% (9.4% of the semi-rigid and 2.7% of the hydraulic prostheses) and infection led to implant removal in 5.6% of the patients.
Editorial comment: Penile prosthesis implantation offers to paraplegic patients restoration of sexual activity, improving their quality of life and their self esteem. Literature data, as well as the present study, show that spinal cord injury patients are at increased risk for periprosthetic infection and erosion. The use of an external catheter with the associated break down of the genital skin, intermittent urethral catheterization and urinary tract infections are the main causes for the increased incidence of infection. Such factors should be carefully considered when prosthesis implantation is proposed in patients with lack of interest in sexual activity, in order to facilitate external catheter drainage. Prosthesis erosion occurs also more often in spinal cord injury patients, mainly due to ischemia and lack of sensation. The constant pressure that the device exerts against the tissue is minimal when in¯atable prosthesis are used. Paraplegics should be well informed of such complications and should be encouraged to try intracavernosal pharmacotherapy or vacuum constriction devices ®rst. Sensory conduction velocity of dorsal nerve of the penis (SCD) was performed in 24 impotent patients before and after a 20 mg injection of prostaglandin E1. Recordable potential at rest was achieved in ®ve patients. After injection recording was feasible in 10 more patients, while the mean amplitude increased considerably. Overall, pharmacologic erection was helpful in 37.5% of the cases.
Editorial comment: Peripheral sensory neuropathies (diabetes, alcoholism) are not uncommon and may affect the dorsal nerve of the penis. Providing sensory information from the surface of the penis, the dorsal nerve plays an important role in normal sexual function, as its impairment adversely affects the patient's ability to sustain an erection. However, electrophysiologic investigations currently available are either insensitive or inappropriate. The authors proposed the performance of SCV after injection of vasoactive agents as technical easier and more reliable method. They believe that the higher amplitudes observed after injection is due to a correct interelectrode distance measurement, as full tumescence may straighten the nerve at an individual and physiologic length. Their study clearly demonstrates factors that may in¯uence the recordings, explaining the controversial results of the neurophysiologic testing in the literature. From the clinical point of view, as men with neurogenic impotence usually respond well to intracavernosal pharmacotherapy and the number of patients with a treatable neurologic disease is very small, a`goaloriented' approach to management seems reasonable.
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